Actively Recruiting
Tele-education in Patients With a Moderate Depressive Episode in Primary Care
Led by University Hospital, Toulouse · Updated on 2026-05-12
220
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying a new tele-education program for adults experiencing moderate depressive episodes. This study focuses on patients managed by their general practitioners in primary care, aiming to improve medication adherence, reduce relapse risk, and enhance patient and professional satisfaction. The program addresses a gap in France, where no psycho-education has been evaluated for this population outside psychiatric care. It uses telemedicine to adapt to recent healthcare changes, especially due to the pandemic. Participants are randomly assigned to either a tele-education program or standard care. The tele-education includes five weekly sessions, each about 60 minutes, covering personalized information on depression symptoms, treatment, diet, coping strategies, and support from family and friends. The final session summarizes what was learned and shares it with the patient’s general practitioner. The control group receives usual care plus an educational booklet on depression. During the study, participants will be monitored by their general practitioner and may also see a psychologist. They will complete questionnaires to assess medication adherence six months after joining and evaluate the tele-education's effectiveness three months after inclusion. The study includes ongoing support, with psychiatrists available for advice if needed, and focuses on improving daily functioning and treatment compliance over time.
CONDITIONS
Brief Title
Paramedical Tele-education on Moderate Depressive Episodes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Presenting a depressive episode of moderate intensity according to the Diagnostic and Statistical Manual (DSM)-V
- Have a prescription for an antidepressant started less than 2 months before joining the trial
- Health status compatible with follow-up by their general practitioner
- Have internet access at home with a computer and ability to use the digital platform
You will not qualify if you...
- Unable to complete self-questionnaires due to language barrier or other reasons
- Already participated in a psycho-education or therapeutic education program for depression
- Health status requiring follow-up by a psychiatrist
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
screening and enrollment visit
Duration - 5 weeks
Participants in the experimental group will receive a tele-education program consisting of 5 weekly individual sessions focusing on depression symptoms, health and diet measures, illness destigmatization, family and social support, treatment information, and session summaries. Participants in the control group will continue their usual care and receive an educational booklet on depression.
5 weekly sessions (remote)
Duration - Up to 6 months post inclusion
Participants may be monitored by their general practitioner or psychologist, with questionnaires completed to assess medication adherence and effectiveness of the tele-education up to 6 months after inclusion.
Questionnaire assessments at 3 and 6 months post inclusion
Trial Site Locations
Total: 1 location
1
Chu Toulouse
Toulouse, Occitanie, France, 31000
Actively Recruiting
Research Team
M
Marion LASSERRE, NURSE
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here